Jinghang Xu

813 total citations
38 papers, 452 citations indexed

About

Jinghang Xu is a scholar working on Epidemiology, Hepatology and Pharmacology. According to data from OpenAlex, Jinghang Xu has authored 38 papers receiving a total of 452 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Epidemiology, 28 papers in Hepatology and 5 papers in Pharmacology. Recurrent topics in Jinghang Xu's work include Liver Disease Diagnosis and Treatment (28 papers), Hepatitis B Virus Studies (20 papers) and Hepatitis C virus research (17 papers). Jinghang Xu is often cited by papers focused on Liver Disease Diagnosis and Treatment (28 papers), Hepatitis B Virus Studies (20 papers) and Hepatitis C virus research (17 papers). Jinghang Xu collaborates with scholars based in China, United States and Hong Kong. Jinghang Xu's co-authors include Yanyan Yu, Ping An, Cheryl A. Winkler, Qiao Zhan, Zheng Zeng, Xiaoyuan Xu, Hani El‐Nezami, Shengliang Xin, Ying Han and Hui Zhuang and has published in prestigious journals such as PLoS ONE, IEEE Access and Frontiers in Immunology.

In The Last Decade

Jinghang Xu

35 papers receiving 447 citations

Peers

Jinghang Xu
Yuta Wakui Japan
Hiroyuki Motoyama Japan
Chongyang Zhang China
Satoshi Tsunematsu Japan
Maciej Jabłkowski Poland
Pir Ahmad Shah United States
Zhujun Cao China
Tomoaki Iwata Japan
Rongtao Lai China
Marcelle de Carvalho Ribeiro United States
Yuta Wakui Japan
Jinghang Xu
Citations per year, relative to Jinghang Xu Jinghang Xu (= 1×) peers Yuta Wakui

Countries citing papers authored by Jinghang Xu

Since Specialization
Citations

This map shows the geographic impact of Jinghang Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jinghang Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jinghang Xu more than expected).

Fields of papers citing papers by Jinghang Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jinghang Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jinghang Xu. The network helps show where Jinghang Xu may publish in the future.

Co-authorship network of co-authors of Jinghang Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Jinghang Xu. A scholar is included among the top collaborators of Jinghang Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jinghang Xu. Jinghang Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Xiaoyuan, Wengang Li, Ying Han, et al.. (2025). Chinese Guidelines on the Management of Hepatic Encephalopathy in Cirrhosis (2024). Journal of Clinical and Translational Hepatology. 0(0). 0–0. 1 indexed citations
2.
Xu, Jinghang, Sa Wang, Dazhi Zhang, et al.. (2022). One hundred and ninety-two weeks treatment of entecavir maleate for Chinese chronic hepatitis B predominantly genotyped B or C. World Journal of Clinical Cases. 10(28). 10085–10096. 3 indexed citations
3.
4.
Xu, Jinghang, Yanan Fan, Yanyan Yu, et al.. (2022). A Multicenter Real-World Study Evaluating the Hepatoprotective Effect of Polyene Phosphatidylcholine Against Chronic Hepatitis B. Frontiers in Medicine. 9. 842098–842098. 3 indexed citations
5.
Tian, Yu, Jinghang Xu, Yifan Han, et al.. (2022). Dynamics of Hepatitis B Virus Pregenomic RNA in Chronic Hepatitis B Patients With Antiviral Therapy Over 9 Years. Frontiers in Medicine. 9. 851717–851717. 4 indexed citations
6.
Xin, Shengliang, et al.. (2022). A case report of hepatitis B virus reactivation 19 months after cessation of chemotherapy with rituximab. Frontiers in Immunology. 13. 1083862–1083862.
7.
8.
Zhan, Qiao, et al.. (2021). Human immune repertoire in hepatitis B virus infection. World Journal of Gastroenterology. 27(25). 3790–3801. 9 indexed citations
9.
Xu, Jinghang, Qian Kang, Hongyu Chen, et al.. (2021). Factors and virological significance of hepatitis B virus pregenomic RNA status after 5 years of antiviral therapy. International Journal of Infectious Diseases. 105. 418–423. 5 indexed citations
10.
Xu, Jinghang, et al.. (2021). Predictive Nomograms for Clinical Outcomes in Hepatitis B-Related Cirrhosis Patients Receiving Antiviral Therapy. Infection and Drug Resistance. Volume 14. 2707–2719. 3 indexed citations
11.
Xin, Shengliang, et al.. (2020). Efficacy of serum miRNA test as a non-invasive method to diagnose nonalcoholic steatohepatitis: a systematic review and meta-analysis. BMC Gastroenterology. 20(1). 186–186. 25 indexed citations
12.
Xu, Jinghang, et al.. (2020). Human genetic susceptibility to hepatitis B virus infection. Infection Genetics and Evolution. 87. 104663–104663. 8 indexed citations
13.
Xu, Xiaoyuan, Huiguo Ding, Wengang Li, et al.. (2020). Chinese guidelines on the management of liver cirrhosis (abbreviated version). World Journal of Gastroenterology. 26(45). 7088–7103. 65 indexed citations
14.
Xu, Jinghang, Ping An, Cheryl A. Winkler, & Yanyan Yu. (2020). Dysregulated microRNAs in Hepatitis B Virus-Related Hepatocellular Carcinoma: Potential as Biomarkers and Therapeutic Targets. Frontiers in Oncology. 10. 1271–1271. 50 indexed citations
15.
Xin, Shengliang, et al.. (2020). Abnormal Liver Function Tests of Patients with Coronavirus Disease 2019 in Mainland China: A Systematic Review and Meta- Analysis. Journal of Gastrointestinal and Liver Diseases. 29(2). 219–226. 10 indexed citations
16.
An, Ping, Jinghang Xu, Yanyan Yu, & Cheryl A. Winkler. (2018). Host and Viral Genetic Variation in HBV-Related Hepatocellular Carcinoma. Frontiers in Genetics. 9. 261–261. 102 indexed citations
17.
Wu, Qingqing, Jieming Zhong, Songhua Chen, et al.. (2016). Laboratory-Based Surveillance of Extensively Drug-Resistant Tuberculosis in Eastern China. Microbial Drug Resistance. 23(2). 236–240. 4 indexed citations
18.
19.
Chen, Jie, et al.. (2012). Three cases of acute gastroenteritis caused by high-level macrolideresistant Campylobacter: Drug resistance mechanisms and clinical characteristics. Scandinavian Journal of Infectious Diseases. 44(7). 541–543. 1 indexed citations
20.
Gong, Qi, Xiao‐Fei Kong, Zhitao Yang, et al.. (2009). Association study of IFNAR2 and IL10RB genes with the susceptibility and interferon response in HBV infection. Journal of Viral Hepatitis. 16(9). 674–680. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yuta Wakui Breakdown of academic impact, for papers by Hiroyuki Motoyama Breakdown of academic impact, for papers by Chongyang Zhang Breakdown of academic impact, for papers by Satoshi Tsunematsu Breakdown of academic impact, for papers by Maciej Jabłkowski Breakdown of academic impact, for papers by Pir Ahmad Shah Breakdown of academic impact, for papers by Zhujun Cao Breakdown of academic impact, for papers by Tomoaki Iwata Breakdown of academic impact, for papers by Rongtao Lai Breakdown of academic impact, for papers by Marcelle de Carvalho Ribeiro
Rankless by CCL
2026